
==== Front
BMC Womens Health
BMC Womens Health
BMC Women's Health
1472-6874
BioMed Central London

3339
10.1186/s12905-024-03339-x
Research
Association between weight-adjusted waist index and overactive bladder syndrome among adult women in the United States: a cross-sectional study
Shang Yilei 1
Chen Jiexin 1
http://orcid.org/0000-0001-7136-5996
Tai Yanghao tyh2018202@163.com

2
1 https://ror.org/0145fw131 grid.221309.b 0000 0004 1764 5980 Beijing Normal University Hong Kong Baptist University United International College, Zhuhai, China
2 grid.263452.4 0000 0004 1798 4018 Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Tongji Shanxi Hospital, Taiyuan, 030032 China
4 9 2024
4 9 2024
2024
24 4888 7 2024
27 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Purpose

The weight-adjusted waist index (WWI) is a recently developed index for measuring obesity. The aim of this study was to investigate the association between WWI levels and overactive bladder (OAB) in a nationally representative population.

Methods

This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES) database between 2007 and 2016. OAB was defined as the Overactive Bladder Syndrome Symptom Score (OABSS, score ≥ 3). The WWI index was calculated as the square root of waist circumference (WC, cm) divided by body weight (kg). We used weighted logistic regression models to assess the relationship between the WWI index and OAB in adult women. The reliability of the findings was assessed using restricted cubic spline, subgroup analysis.

Results

A total of 10,563 individuals were included in the study, and the prevalence of OAB was 18.6%. Higher WWI was associated with an increased risk of overactive bladder syndrome. In model 1 with unadjusted variables (OR = 1.148; 95% CI = 1.148–1.149, p < 0.001), model 2 (OR = 1.253; 95% CI = 1.253–1.254, p < 0.001) and model 3 with fully adjusted variables (OR = 1.215; 95% CI = 1.214–1.215, p < 0.001) in which the association was significant. The results of the subgroup analyses showed that age stratification and stroke status could modify this association between WWI and OAB. Restricted cubic spline showed a nonlinear relationship between WWI and OAB (p for nonlinear < 0.05).

Conclusion

Weight-adjusted waist circumference index (WWI) values are positively associated with the risk of developing OAB in adult women in the United States, but further studies are needed to elucidate the causal relationship between WWI and OAB.

Keywords

Overactive bladder
Obesity
Weight-adjusted waist index
NHANES
Population-based studies
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Overactive bladder (OAB) is an idiopathic disorder characterized by urinary urgency, usually with nocturia and frequency, with or without urge incontinence [1]. The International Continence Society (ICS) has identified overactivity of the detrusor muscles as the main cause of OAB, but other forms of urethro-bladder dysfunction may also contribute [2]. In recent years, OAB has affected millions of men and women worldwide and the prevalence has increased. The overall prevalence of OAB in the United States has increased from 16.5% in 2000–2001 to 38.5% in 2021–2022, and is increasing with age [3, 4]. In Europe, the prevalence of OAB is 16.6% among people under 40 years of age and the incidence of urge incontinence is higher in women than in men [5]. Some studies have confirmed that moderate-to-severe OAB may lead to mood disorders resulting in a significant reduction in quality-of-life [6, 7]. Urinary incontinence is an underestimated health problem. Patients need to understand their health through detailed memory removal collection and physical examination to determine the type of incontinence and provide the best treatment. Existing available medical techniques and medications have been reported to be effective in improving overactive bladder syndrome [8]. Opemifene has shown high efficacy in improving overactive bladder symptoms in postmenopausal women affected by vulvovaginal atrophy [9]. However, the primary goal of treating OAB is to relieve symptoms because it cannot reverse pathophysiologic abnormalities. OAB also carries a significant economic burden, with the societal costs totaling more than $14 billion [10]. Risk factors for OAB include diet, physical activity, chronic diseases, and neurologic disorders [11]. Few population-based studies have investigated the relationship between OAB and human health. Therefore, there is an urgent need to fill this research gap using reliable and representative data.

The prevalence of obesity has reached epidemic levels globally and is becoming increasingly common among women of childbearing age [12]. Studies have shown that obesity is an important factor in overactive bladder disease [13]. Although body mass index (BMI) is a common assessment of obesity, it cannot be used to differentiate between fat and muscle mass [14]. In addition, BMI is influenced by differences in a variety of demographic factors, such as age, sex, and ethnicity [15]. The obesity paradox challenges trust in the role of BMI. In contrast to BMI, waist circumference (WC) shows a strong correlation with abdominal fat accumulation [16]. However, the correlation between BMI and WC limits the function of WC as an independent obesity marker. The weight-adjusted waist index (WWI) is a novel obesity index that combines the strengths of the WC and shows a stable correlation with abdominal fat accumulation [17]. It is calculated as waist circumference divided by the square root of body weight. WWI corrects for the correlation between WC and BMI primarily by reflecting central obesity independent of body weight. WWI has been shown to correlate with a variety of disorders such as erectile dysfunction, depression, and female infertility [18–21]. A large number of epidemiological studies have emphasized the important role of obesity, especially abdominal obesity, in OAB [22]. It is valuable that our study introduces the novel obesity indicator WWI to explore this progress. However, to our knowledge, the role of the WWI index concerning OAB in adult women remains unclear. According to previous studies, the transformation of numerical variables into categorical variables by equating them helps to further analyse the sensitivity of the model and assess its robustness. Considering the median after equalisation as a continuous variable, it was assessed whether the non-linear trend was still statistically significant. Using the National Health and Nutrition Examination Survey (NHANES) database, this study sought to explore the association between the WWI index and the prevalence of OAB among adult women in a nationally representative sample.

Materials and methods

Data sources

This population-based study used data from NHANES, a national survey conducted by the National Center for Health Statistics of the U.S. Centers for Disease Control and Prevention, using a randomized, stratified, multistage approach. Participants underwent a series of assessments, including physical examinations, health and nutrition questionnaires, and laboratory assessments. The NHANES study protocol was approved by the Ethics Review Board of the National Center for Health Statistics. The full detailed design and data are available at https://www.cdc.gov/nchs/nhanes/. Data were obtained and combined from 5 NHANES cycles: 2007–2008, 2009–2010, 2011–2012, 2013–2014, and 2015–2016 (50,588 participants). Participants who were male, under 20 years of age, pregnant, and participants without information on WWI index, OAB diagnostic data, and other covariates were excluded. Ultimately, a total of 10,563 eligible patients were enrolled in the study. Figure 1 is a flowchart of participant inclusion and exclusion. The NCHS Research Ethics Review Board approved the NHANES study protocol based on Helsinki declaration, and participants provided written informed consent at enrollment (https://www.cdc.gov/nchs/nhanes/irba98.htm). Ethical approval and consent were not required as the study was based on publicly available de-identified data.Fig. 1 Flowchart depicting participant selection in the study

Exposure and outcome definitions

WWI index was used as an exposure variable, defined as the square root of waist circumference divided by body weight. Continuous data were categorized into subtypes according to the trichotomy method. Q1 was defined as WWI ≤ 6.96). Q2 was defined as 6.96 < WWI ≤ 8.07). Q3 was defined as WWI > 8.07. The diagnosis of OAB was defined according to the International Association for Urological Control. OAB is a symptomatic syndrome characterized by concurrent urgency to urinate, usually with urinary frequency and nocturia, with or without urgency urinary incontinence (UUI), and in the absence of urinary tract infections or other obvious pathology. We used the Nephrology Urology Questionnaire from the NHANES database for the assessment of OAB. "Have you ever urinated before going to the bathroom" and "How often does this happen?" were used to assess the severity of UUI. "How many times did you urinate at night? Used to assess the severity of nocturia. Based on previous study [23], we quantified the severity of OAB for each participant by means of the novel Overactive Bladder Symptom Score (OABSS) scale, and participants with an overall OABSS score of ≥ 3 were considered as OAB. Important to emphasize is that participants with an OABSS score of ≥ 3 were considered to have overactive bladder regardless of whether the incontinence score was 0 or not. This study did not provide more detailed typing of overactive bladder syndrome.

Covariate definitions

We collected demographic data and other covariates from the NHANES database, including age, race, Ratio of family income to poverty (RIP), education level, marital status, physical activity, smoking status, alcohol consumption, diabetes, coronary heart disease, stroke, and malignancy. The RIP is the ratio of income to the family poverty line set by the U.S. Census Bureau and is a measure of socioeconomic status. According to "Had at least 12 alcohol drinks/lifetime" and "Had at least 12 alcohol drinks/1 year?", drinkers are categorized as current, former, and never drinkers. Smokers were categorized as current, former, or never smokers based on "Smoked at least 100 cigarettes in life" and "Do you now smoke cigarettes". Self-reported diabetes was also defined based on questionnaire information. The presence of coronary heart disease, stroke, and malignant neoplasm were defined based on self-reported history of specific diseases. The details of the conversion of the Nephrology Urology Questionnaire into OABSS scores in Fig. 2.Fig. 2 Details of the conversion of the Nephrology Urology Questionnaire into OABSS scores

Statistical analysis

Participants' baseline characteristics were described as continuous and categorical variables based on OAB prevalence. Continuous variables were expressed as mean ± standard deviation and categorical variables were expressed as numbers and percentages. Weighted t-tests and chi-square tests were used to compare the baseline characteristics of these participants. Logistic regression models were used to assess the association between OAB and WWI. Three models with different levels of covariate adjustment were used (model 1, no adjustment for covariates; model 2, adjustment for age, race, RIP, education level, marital status; and model 3, adjustment for all covariates). Odds ratios (ORs) and 95% confidence intervals (CIs) for OAB patients with different WWIs. In the model 3, we used WWI as a continuous variable and restricted cubic spline (RCS) to reveal the dose–response relationship between WWI and OAB risk. The multiple logistic regression models were categorized into categorical and continuous models. Based on previous studies of the correlation between obesity indicator measures and disease, this study used tertiles for grouping variables [24–26]. In the categorical model, WWI was categorized into thirds and nonlinear trends were assessed by treating the median of each trichotomy as a continuous variable. Finally, we used subgroup analyses stratified by age, ethnicity, RIP, education level, marital status, physical activity, smoking status, alcohol consumption, hypertension, diabetes, coronary heart disease, stroke, and malignancy, and performed interaction analyses to check for differential associations between subgroups. A bilateral p-value < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS 26.0.

Results

Baseline characteristics of participants

A total of 10,563 eligible participants were ultimately enrolled in the study (from 2007–2016 NHANES). Statistically, a total of 2,412 participants (18.6%) with OAB and 8,142 healthy participants(81.4%). Table 1 shows the characteristics of the study participants. The population-weighted mean age was 57.24 ± 15.91 years. We observed statistically significant differences in all variables in the OAB prevalent population (p value < 0.05). Participants in the prevalent group were older, less educated, had low RIP, comorbid diabetes, coronary heart disease, stroke, and malignant tumors compared to the non-OAB group. In addition, participants in the disease group were more likely to drink alcohol, smoke, and engage in excessive physical activity. Table 1 Baseline characteristics of participants based on prevalence of OAB

Characteristics	Participant No. (weighted, %)	P Value	
With OAB	Without OAB	
N	2,421 (18.6%)	8142 (81.4%)		
Age (mean ± SE), year	58.03 ± 15.78 (57.24 ± 15.91)	46.97 ± 17.01 (46.08 ± 16.38)	 < 0.001	
Race			 < 0.001	
 Mexican American	354 (7.1%)	1200 (7.2%)		
 Other Hispanic	305 (6.2%)	872 (5.1%)		
 Non-Hispanic White	947 (64.2%)	3696 (70.8%)		
 Non-Hispanic Black	674 (17.7%)	1499 (9.7%)		
 Other Race—Including Multi-Racial	141 (4.8%)	875 (7.1%)		
Education level			 < 0.001	
 Less than 9th grade	372 (8.7%)	581 (3.6%)		
 9-11th grade (Includes 12th grade with no diploma)	474 (16.5%)	957 (8.7%)		
 High school graduate/GED or equivalent	546 (24.2%)	1729 (20.1%)		
 Some college or AA degree	708 (32.8%)	2686 (34.5%)		
 College graduate or above	321 (17.8%)	2171 (33.1%)		
Marital status			 < 0.001	
 Married	955 (46.2%)	3978 (54.1%)		
 Widowed	467 (15.9%)	705 (6.7%)		
 Divorced	407 (16.4%)	990 (11.7%)		
 Separated	131 (4.0%)	274 (2.2%)		
 Never married	330 (11.6%)	1560 (17.5%)		
 Living with partner	131 (5.9%)	635 (7.8%)		
 RIP	2.02 ± 1.47(2.41 ± 1.59)	2.57 ± 1.64(3.05 ± 1.65)	 < 0.001	
Drinking			 < 0.001	
 Never	569 (18.3%)	1539 (13.7%)		
 Past	517 (18.9%)	1424 (14.6%)		
 Now	1335 (62.8%)	5179 (71.7%)		
Diabetes			 < 0.001	
 Yes	594 (21.3%)	735 (6.5%)		
 No	1827 (78.7%)	7407 (93.5%)		
Vigorous recreational activities			 < 0.001	
 Yes	179 (9.4%)	1670 (24.6%)		
 No	2242 (90.6%)	6472 (75.4%)		
Moderate recreational activities			 < 0.001	
 Yes	740 (34.9%)	3580 (49.7%)		
 No	1681 (65.1%)	4562 (50.3%)		
Smoking			 < 0.001	
 Never	1403 (54.7%)	5270 (61.7%)		
 Past	533 (24.0%)	1451 (20.6%)		
 Now	485 (21.3%)	1421 (17.7%)		
Coronary heart disease			 < 0.001	
 Yes	112 (4.7%)	151 (1.6%)		
 No	2309 (95.3%)	7991 (98.4%)		
Stroke			 < 0.001	
 Yes	162 (5.8%)	208 (2.1%)		
 No	2259 (94.2%)	7934 (97.9%)		
Cancer or malignancy			 < 0.001	
 Yes	345 (17.7%)	719 (9.8%)		
 No	2076 (82.3%)	7423 (90.2%)		
 WWI (mean ± SE)	7.89 ± 1.53(7.93 ± 1.53)	7.58 ± 1.41(7.64 ± 1.38)	 < 0.001	
Continuous variables were presented as mean with standard deviation (mean t S), and categorical variables were expressed as proportion. Continuous variables were analyzed via one-way ANOVA; categorical variables were analyzed using the Chi-square test or the Fisher's exact test, and P-value less than 0.05 was considered statistically significant

The relationship between OAB and WWI

Three weighted univariate and multivariate regression models were used to assess whether the relationship between WWI and the prevalence of OAB in adult women in the United States was statistically significant. Based on these three models, we observed a positive and statistically significant association between WWI and OAB prevalence. Higher WWI was associated with an increased risk of overactive bladder syndrome. In our model 1 (OR = 1.148; 95% CI = 1.148—1.149, p < 0.001), model 2 (OR = 1.253; 95% CI = 1.253—1.254, p < 0.001) and model 3 (OR = 1.215; 95% CI = 1.214—1.215, p < 0.001) in which the association was significant. In the fully adjusted model, each unit increase in WWI was associated with a 21.5% increased risk of developing overactive bladder syndrome (Table 2). Table 2 Weighted regression models and trend tests elucidating the association between WWI and prevalence of OAB

WWI	SD	OAB OR (95% CI)	
Model 1	P Value	Model 2	P Value	Model 3	P Value	
Per l increment	7.07	1.148 (1.148–1.149)	 < 0.001	1.253 (1.253–1.254)	 < 0.001	1.215 (1.214–1.215)	 < 0.001	
Q1 (≤ 6.96)	6.32	1	 < 0.001	1	 < 0.001	1	 < 0.001	
Q2 (6.96–8.07)	7.48	1.064 (1.063–1.066)	 < 0.001	1.200 (1.199–1.202)	 < 0.001	1.166 (1.164–1.167)	 < 0.001	
Q3 (> 8.07)	9.29	1.558 (1.556–1.560)	 < 0.001	1.984 (1.981–1.986)	 < 0.001	1.745 (1.742–1.747)	 < 0.001	
P for trend			 < 0.001		 < 0.001		 < 0.001	
Model 1 was adjusted for none

Model 2 was adjusted for age, sex, race, education level, and marital status

Model 3 was adjusted for age, race, RIP, education level, marital status, physical activity, smoking status, alcohol use, diabetes, coronary heart disease, stroke, and malignancy

Using restricted cubic spline, a nonlinear relationship between WWI and OAB risk was found in all three models adjusted for multiple covariates (Fig. 3) (p < 0.05).Fig. 3 Analysis of the Measured Response Relationship Between WWI and OAB. A Model 1 was adjusted for none. B Model 2 was adjusted for age, sex, race, education level, and marital status. C Model 3 was adjusted for age, race, RIP, education level, marital status, physical activity, smoking status, alcohol use, diabetes, coronary heart disease, stroke, and malignancy. The solid blue line indicates the OR and the blue shaded area indicates the 95% CI

Subgroup analysis

Subgroup analyses were performed to assess the association between WWI and the prevalence of OAB in different populations. As shown in Table 3, WWI was positively associated with the risk of OAB prevalence in specific populations (P < 0.05). These characteristics included age, race, education level, marital status, RIP, history of alcohol consumption, history of smoking, diabetes mellitus, recreational activities, history of coronary heart disease, history of stroke, and malignancy. Significant interactions were found within subgroups based on age (≤ 40, 41–60, > 60) (P for Interaction = 0.032). In individuals under 40 years of age, each 1-unit increase in WWI was associated with a 25% increase in the odds of having OAB. For individuals aged 41 to 60 years, each 1-unit increase in WWI was associated with a 26.7% increase in the odds of having OAB. For those older than 60 years, each 1-unit increase in WWI was associated with a 17.4% increase in the odds of having OAB. We also found some degree of interaction in the stroke (yes/no) subgroup (P for Interaction = 0.030). In the non-stroke population, each 1-unit increase in WWI was associated with a 15.9% increase in the incidence of OAB. Table 3 Subgroup analysis of the association between WWI and OAB. Analyses were adjusted for age, race, RIP, education level, marital status, physical activity, smoking status, alcohol use, diabetes, coronary heart disease, stroke, and malignancy

Subgroup	OAB [OR (95% CI)]	P Value	P for Interaction	Subgroup	OAB [OR (95% CI)]	P Value	P for Interaction	
Age			0.032	Drinking			0.541	
 ≤ 40	1.250 (1.175 – 1.329)	 < 0.001		Never	1.115 (1.044 – 1.190)	0.001		
 41–60	1.267 (1.204 – 1.334)	 < 0.001		Past	1.117 (1.048 – 1.190)	0.001		
 > 60	1.174 (1.109 – 1.243)	 < 0.001		Now	1.187 (1.140 – 1.237)	 < 0.001		
Race			0.051	Diabetes			0.162	
 Mexican American	1.159 (1.057 – 1.272)	0.002		Yes	1.032 (0.961 – 1.109)	0.381		
 Other Hispanic	1.207 (1.094 – 1.333)	 < 0.001		No	1.136 (1.097 – 1.176)	 < 0.001		
 Non-Hispanic White	1.076 (1.023 – 1.131)	0.004		Vigorous recreational activities			0.504	
 Non-Hispanic Black	1.080 (1.019 – 1.144)	0.009		Yes	1.234 (1.108 – 1.375)	 < 0.001		
 Other Race—Including Multi-Racial	1.224 (1.074 – 1.395)	0.002		No	1.129 (1.094 – 1.166)	 < 0.001		
Education level			0.404	Moderate recreational activities			0.465	
 Less than 9th grade	1.207 (1.083 – 1.346)	0.001		Yes	1.212 (1.149 – 1.280)	 < 0.001		
 9-11th grade (Includes 12th grade with no diploma)	1.165 (1.081 – 1.255)	 < 0.001		No	1.116 (1.076 – 1.158)	 < 0.001		
 High school graduate/GED or equivalent	1.137 (1.067 – 1.212)	 < 0.001		Smoking			0.643	
 Some college or AA degree	1.153 (1.094 – 1.215)	 < 0.001		Never	1.142 (1.099 – 1.188)	 < 0.001		
 College graduate or above	1.252 (1.155 – 1.356)	 < 0.001		Past	1.131 (1.056 – 1.210)	 < 0.001		
Marital status			0.077	Now	1.169 (1.090 – 1.253)	 < 0.001		
 Married	1.149 (1.094 – 1.207)	 < 0.001		Coronary heart disease			0.150	
 Widowed	1.185 (1.084 – 1.296)	 < 0.001		Yes	1.200 (0.991 – 1.453)	0.062		
 Divorced	1.186 (1.091 – 1.290)	 < 0.001		No	1.153 (1.118 – 1.189)	 < 0.001		
 Separated	1.173 (1.021 – 1.348)	0.024		Stroke			0.030	
 Never married	1.226 (1.145 – 1.312)	 < 0.001		Yes	1.040 (0.906 – 1.193)	0.581		
 Living with partner	1.224 (1.088 – 1.377)	0.001		No	1.159 (1.123 – 1.196)	 < 0.001		
RIP			0.226	Cancer or malignancy			0.190	
  ≤ 1.0	1.154 (1.092 – 1.219)	 < 0.001		Yes	1.162 (1.059 – 1.276)	0.002		
 1.1–4.0	1.133 (1.086 – 1.181)	 < 0.001		No	1.153 (1.117 – 1.191)	 < 0.001		
  > 4.0	1.155 (1.070 – 1.247)	 < 0.001						

Discussion

In this study, based on a representative sample of US adult women, we observed a significant association between WWI and OAB. Both univariate and multivariate logistic regression analyses showed that WWI levels were associated with increased prevalence of OAB. Conversion of WWI from a continuous to a categorical variable showed a significant increase in the prevalence of OAB in Q2 (6.96 < WWI ≤ 8.07) and Q3 (> 8.07) compared to Q1 (WWI ≤ 6.96)). Further analysis of the dose–response relationship showed a nonlinear positive correlation between WWI and OAB prevalence. Subgroup analyses showed that the positive correlation between WWI and OAB prevalence varied across age and stroke populations. The stability of the correlation between WWI and OAB prevalence in other subgroups remained consistent. Stroke and age can modify the relationship between WWI and OAB. In particular, increased WWI was associated with a significantly higher risk of OAB in the non-stroke group, but no significant correlation was found between WWI and OAB in the stroke group. In addition, the correlation between WWI and OAB was stronger in the 41–60-year-old group.

Our results in subgroup analyses found a significant positive correlation between WWI and OAB in the non-stroke population (OR = 1.159 95% CI 1.123—1.196, P < 0.001). Post-stroke develop neurogenic detrusor overactivity is the most common urodynamic manifestation in stroke patients. Approximately 10% of stroke patients may develop sphincter pseudo-synergia after stroke [27]. After the acute phase, it is the post-stroke patient whose lower urinary tract symptoms are primarily characterized by bladder overactivity. After the recovery period, bladder dysfunction and urge incontinence may still be present in post-stroke patients [28]. A growing number of studies have shown that overactive bladder disorder is a common disorder in middle-aged women [27]. The OAB prevalence increases with age, especially in the middle-aged population (age ≥ 40 years) [29].

Numerous studies have confirmed that high BMI is a risk factor for urinary incontinence in women [30, 31]. A longitudinal study based on a Chinese population suggests that incontinence remission rates are lower in women with higher BMIs [32]. Women with larger abdominal diameters have a greater chance of experiencing lower urinary tract symptoms (urinary incontinence, nocturia, and urgency) [33]. Since obesity is a modifiable risk factor, weight loss programs may help reduce symptoms or incidence of OAB [34]. BMI is widely used worldwide as an indicator of overweight and obesity. However, it does not reflect obesity types such as apple-shaped obesity (upper body obesity) and pear-shaped obesity (lower body obesity) due to poor estimates of overall obesity. But the obesity paradox remains. The reason for the controversy may partly stem from the inability of traditional metrics to differentiate between fat distribution and muscle mass [14]. The WWI takes into account the ratio of waist circumference to height, which provides more precise information about fat distribution [17]. There is a lack of studies exploring the correlation between OAB and the WWI, which may be one of the directions for future research in assessing obesity and OAB.

Several potential mechanisms could explain this positive correlation in the relationship between WWI and OAB. First, increased WWI may reflect visceral fat accumulation, particularly in the abdomen. This fat accumulation can exert physical pressure on the bladder and pelvis, leading to compression of the bladder neck and urethra, which can increase the risk of urinary incontinence. Visceral fat may also affect the function of the pelvic floor muscles, which in turn affects the ability of the urethra to close and control urination [35]. Second, obesity is closely associated with a state of chronic inflammation [36]. The accumulation of large amounts of visceral fat can lead to the release of pro-inflammatory factors, which can damage the pelvic floor structures and weaken the tone and elasticity of the urinary sphincter. Chronic inflammation may directly or indirectly affect the mechanisms of urinary incontinence [37]. Inflammation may affect nerve conduction, the pelvic floor nerves, and the central nervous system that controls urethral and bladder function. This may include changes in nerve conduction velocity, neuronal damage or degeneration, which in turn affects urethral perception and control and increases the risk of urinary incontinence [38]. In addition, obesity can lead to changes in hormone levels, such as insulin resistance. These hormonal changes may affect the strength and function of the pelvic floor muscles, which may affect urethral control. Interaction between reduced oestrogen production and prevalence of obesity in menopausal women. Oestrogen and the oestrogen receptor regulate glucose and lipid metabolism, and disturbances in this metabolic signaling contribute to the risk of metabolic syndrome. It is characterized by changes in the lipid profile and the accumulation of predominantly abdominal fat [39]. Decreased estrogen levels may lead to atrophy and decreased function of the pelvic floor muscles as well as damage to the urethral mucosal barrier which can increase the risk of urinary incontinence [40]. Finally, people with obesity usually have unhealthy diet and exercise habits. They may consume large amounts of stimulating foods or beverages, such as coffee and carbonated beverages [41], which may irritate the bladder and lead to frequent or urgent urination. They may often be physically inactive, and prolonged physical inactivity may lead to weakening and decreased function of the pelvic floor muscles [42]. Obesity may lead to psychological problems such as body image dissatisfaction, social rejection, or anxiety. Anxiety, depression, or stress may lead to tension in the pelvic floor muscles or overactive bladder [6].

According to recent research, obesity is strongly associated with a wide range of deleterious health outcomes in the context of the current global obesity rate that continues to rise, and in particular is strongly linked to the problem of OAB. This study provides new evidence of a significant association between WWI and the development of OAB, which is one of the key therapeutic targets for future OAB interventions. This study also has several limitations. First, NHANES utilized a multistage sampling design, but selection bias may still exist. Participants may not be representative of the entire population, which may affect the extrapolation of findings. Second, some information was obtained through respondent self-report, such as disease information. This self-reporting bias may have resulted in inaccurate information, which could have affected the results of the study. In addition, this study was a cross-sectional study and only correlations could be inferred and causality over time could not be obtained.

Authors’ contributions

SY: Project development, Data collection, Data analysis, Manuscript writing. CJ: Project development, Data collection, Data analysis, Manuscript writing. TY: Manuscript editing, Result inspection.

Funding

This study was not supported by any funding.

Availability of data and materials

NHANES data used in this work are publicly available. All raw data are available on the NHANES website (https://www.cdc.gov/nchs/nhanes/). Further inquiries can be directed to the corresponding author.

Declarations

Ethics approval and consent to participate

The NCHS Research Ethics Review Board approved the NHANES study protocol, and participants provided written informed consent at enrollment (https://www.cdc.gov/nchs/nhanes/irba98.htm). Ethical approval and consent were not required as the study was based on publicly available de-identified data.

Competing interests

The authors declare no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yilei Shang and Jiexin Chen contributed equally to this work.
==== Refs
References

1. Nambiar AK Arlandis S Bo K European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence Eur Urol 2022 82 1 49 59 10.1016/j.eururo.2022.01.045 35216856
Nambiar AK, Arlandis S, Bo K, et al. European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022;82(1):49–59.35216856 10.1016/j.eururo.2022.01.045
2. Abrams P Cardozo L Fall M The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society Urology 2003 61 1 37 49 10.1016/S0090-4295(02)02243-4 12559262
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.12559262 10.1016/S0090-4295(02)02243-4
3. Stewart WF Van Rooyen JB Cundiff GW Prevalence and burden of overactive bladder in the United States World J Urol 2003 20 6 327 336 10.1007/s00345-002-0301-4 12811491
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.12811491 10.1007/s00345-002-0301-4
4. Sebesta EM Gleicher S Kaufman MR Associations between unmet social needs and overactive bladder J Urol 2022 208 5 1106 1115 10.1097/JU.0000000000002841 36106450
Sebesta EM, Gleicher S, Kaufman MR, et al. Associations between unmet social needs and overactive bladder. J Urol. 2022;208(5):1106–15.36106450 10.1097/JU.0000000000002841
5. Milsom I Abrams P Cardozo L How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 2001 87 9 760 766 10.1046/j.1464-410x.2001.02228.x 11412210
Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760–6.11412210 10.1046/j.1464-410x.2001.02228.x
6. Zuluaga L Caicedo JI Mogollon MP Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study World J Urol 2023 41 5 1381 1388 10.1007/s00345-023-04351-w 36961525
Zuluaga L, Caicedo JI, Mogollon MP, et al. Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study. World J Urol. 2023;41(5):1381–8.36961525 10.1007/s00345-023-04351-w
7. Hughes FJ, Odom MR, Cervantes A, et al. Why are some people with Lower Urinary Tract Symptoms (LUTS) depressed? New evidence that peripheral inflammation in the bladder causes central inflammation and mood disorders. Int J Mol Sci. 2023;24(3):2821.
8. Monti M Fischetti M Santangelo G Urinary incontinence in women: state of the art and medical treatment Minerva Obstet Gynecol 2021 73 2 135 139 10.23736/S2724-606X.20.04635-3 32744453
Monti M, Fischetti M, Santangelo G, et al. Urinary incontinence in women: state of the art and medical treatment. Minerva Obstet Gynecol. 2021;73(2):135–9.32744453 10.23736/S2724-606X.20.04635-3
9. Schiavi MC Zullo MA Faiano P Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms Gynecol Endocrinol 2017 33 12 942 945 10.1080/09513590.2017.1323859 28490209
Schiavi MC, Zullo MA, Faiano P, et al. Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms. Gynecol Endocrinol. 2017;33(12):942–5.28490209 10.1080/09513590.2017.1323859
10. Durden E Walker D Gray S The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States Neurourol Urodyn 2018 37 5 1641 1649 10.1002/nau.23513 29464813
Durden E, Walker D, Gray S, et al. The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States. Neurourol Urodyn. 2018;37(5):1641–9.29464813 10.1002/nau.23513
11. Mckellar K Bellin E Schoenbaum E Prevalence, risk factors, and treatment for overactive bladder in a racially diverse population Urology 2019 126 70 75 10.1016/j.urology.2018.12.021 30597170
Mckellar K, Bellin E, Schoenbaum E, et al. Prevalence, risk factors, and treatment for overactive bladder in a racially diverse population. Urology. 2019;126:70–5.30597170 10.1016/j.urology.2018.12.021
12. Afshin A Forouzanfar MH Reitsma MB Health effects of overweight and obesity in 195 countries over 25 years N Engl J Med 2017 377 1 13 27 10.1056/NEJMoa1614362 28604169
Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.28604169 10.1056/NEJMoa1614362
13. Gregg EW Shaw JE Global health effects of overweight and obesity N Engl J Med 2017 377 1 80 81 10.1056/NEJMe1706095 28604226
Gregg EW, Shaw JE. Global health effects of overweight and obesity. N Engl J Med. 2017;377(1):80–1.28604226 10.1056/NEJMe1706095
14. Heymsfield SB Scherzer R Pietrobelli A Body mass index as a phenotypic expression of adiposity: quantitative contribution of muscularity in a population-based sample Int J Obes (Lond) 2009 33 12 1363 1373 10.1038/ijo.2009.184 19773739
Heymsfield SB, Scherzer R, Pietrobelli A, et al. Body mass index as a phenotypic expression of adiposity: quantitative contribution of muscularity in a population-based sample. Int J Obes (Lond). 2009;33(12):1363–73.19773739 10.1038/ijo.2009.184
15. Jackson AS Stanforth PR Gagnon J The effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study Int J Obes Relat Metab Disord 2002 26 6 789 796 10.1038/sj.ijo.0802006 12037649
Jackson AS, Stanforth PR, Gagnon J, et al. The effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study. Int J Obes Relat Metab Disord. 2002;26(6):789–96.12037649 10.1038/sj.ijo.0802006
16. Lam BC Koh GC Chen C Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore PLoS ONE 2015 10 4 e122985 10.1371/journal.pone.0122985
Lam BC, Koh GC, Chen C, et al. Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE. 2015;10(4):e122985.10.1371/journal.pone.0122985
17. Yu S, Wang B, Guo X, et al. Weight-adjusted-waist index predicts newly diagnosed diabetes in Chinese rural adults. J Clin Med. 2023;12(4):1620.
18. Cao S Hu X Shao Y Relationship between weight-adjusted-waist index and erectile dysfunction in the United State: results from NHANES 2001–2004 Front Endocrinol (Lausanne) 2023 14 1128076 10.3389/fendo.2023.1128076 37181040
Cao S, Hu X, Shao Y, et al. Relationship between weight-adjusted-waist index and erectile dysfunction in the United State: results from NHANES 2001–2004. Front Endocrinol (Lausanne). 2023;14:1128076.37181040 10.3389/fendo.2023.1128076
19. Li M Yu X Zhang W The association between weight-adjusted-waist index and depression: Results from NHANES 2005–2018 J Affect Disord 2024 347 299 305 10.1016/j.jad.2023.11.073 38000467
Li M, Yu X, Zhang W, et al. The association between weight-adjusted-waist index and depression: Results from NHANES 2005–2018. J Affect Disord. 2024;347:299–305.38000467 10.1016/j.jad.2023.11.073
20. Ye J Hu Y Chen X Association between the weight-adjusted waist index and stroke: a cross-sectional study BMC Public Health 2023 23 1 1689 10.1186/s12889-023-16621-8 37658310
Ye J, Hu Y, Chen X, et al. Association between the weight-adjusted waist index and stroke: a cross-sectional study. BMC Public Health. 2023;23(1):1689.37658310 10.1186/s12889-023-16621-8
21. Wen Z Li X Association between weight-adjusted-waist index and female infertility: a population-based study Front Endocrinol (Lausanne) 2023 14 1175394 10.3389/fendo.2023.1175394 37614708
Wen Z, Li X. Association between weight-adjusted-waist index and female infertility: a population-based study. Front Endocrinol (Lausanne). 2023;14:1175394.37614708 10.3389/fendo.2023.1175394
22. Lai HH Helmuth ME Smith AR Relationship between central obesity, general obesity, overactive bladder syndrome and urinary incontinence among male and female patients seeking care for their lower urinary tract symptoms Urology 2019 123 34 43 10.1016/j.urology.2018.09.012 30393054
Lai HH, Helmuth ME, Smith AR, et al. Relationship between central obesity, general obesity, overactive bladder syndrome and urinary incontinence among male and female patients seeking care for their lower urinary tract symptoms. Urology. 2019;123:34–43.30393054 10.1016/j.urology.2018.09.012
23. Lin W Wang H Wu Z Associations between exposure to organophosphate esters and overactive bladder in U.S. adults: a cross-sectional study Front Public Health 2023 11 1186848 10.3389/fpubh.2023.1186848 38026372
Lin W, Wang H, Wu Z, et al. Associations between exposure to organophosphate esters and overactive bladder in U.S. adults: a cross-sectional study. Front Public Health. 2023;11:1186848.38026372 10.3389/fpubh.2023.1186848
24. Yin YH Zhou SY Lu DF Higher waist circumference is associated with increased likelihood of female infertility: NHANES 2017–2020 results Front Endocrinol (Lausanne) 2023 14 1216413 10.3389/fendo.2023.1216413 37937052
Yin YH, Zhou SY, Lu DF, et al. Higher waist circumference is associated with increased likelihood of female infertility: NHANES 2017–2020 results. Front Endocrinol (Lausanne). 2023;14:1216413.37937052 10.3389/fendo.2023.1216413
25. Zhou Y Yang G Peng W Relationship between depression symptoms and different types of measures of obesity (BMI, SAD) in US women Behav Neurol 2020 2020 9624106 10.1155/2020/9624106 33299495
Zhou Y, Yang G, Peng W, et al. Relationship between depression symptoms and different types of measures of obesity (BMI, SAD) in US women. Behav Neurol. 2020;2020:9624106.33299495 10.1155/2020/9624106
26. Zhang Y Song J Li B Association between body roundness index and overactive bladder: results from the NHANES 2005–2018 Lipids Health Dis 2024 23 1 184 10.1186/s12944-024-02174-1 38867211
Zhang Y, Song J, Li B, et al. Association between body roundness index and overactive bladder: results from the NHANES 2005–2018. Lipids Health Dis. 2024;23(1):184.38867211 10.1186/s12944-024-02174-1
27. Yang CF, Huang CY, Wang SY et al. Prevalence of and associated factors for overactive bladder subtypes in middle-aged women: a cross-sectional study. Medicina (Kaunas). 2022;58(3):383.
28. Chiang CH Chen SF Kuo HC Video-urodynamic characteristics of lower urinary tract dysfunctions in patients with chronic brain disorders Neurourol Urodyn 2022 41 1 255 263 10.1002/nau.24806 34605576
Chiang CH, Chen SF, Kuo HC. Video-urodynamic characteristics of lower urinary tract dysfunctions in patients with chronic brain disorders. Neurourol Urodyn. 2022;41(1):255–63.34605576 10.1002/nau.24806
29. Przydacz M Golabek T Dudek P Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study Sci Rep 2020 10 1 19819 10.1038/s41598-020-76846-0 33188254
Przydacz M, Golabek T, Dudek P, et al. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study. Sci Rep. 2020;10(1):19819.33188254 10.1038/s41598-020-76846-0
30. Pang H Lv J Xu T Incidence and risk factors of female urinary incontinence: a 4-year longitudinal study among 24 985 adult women in China BJOG 2022 129 4 580 589 10.1111/1471-0528.16936 34536320
Pang H, Lv J, Xu T, et al. Incidence and risk factors of female urinary incontinence: a 4-year longitudinal study among 24 985 adult women in China. BJOG. 2022;129(4):580–9.34536320 10.1111/1471-0528.16936
31. Townsend MK Danforth KN Rosner B Body mass index, weight gain, and incident urinary incontinence in middle-aged women Obstet Gynecol 2007 110 2 Pt 1 346 353 10.1097/01.AOG.0000270121.15510.57 17666610
Townsend MK, Danforth KN, Rosner B, et al. Body mass index, weight gain, and incident urinary incontinence in middle-aged women. Obstet Gynecol. 2007;110(2 Pt 1):346–53.17666610 10.1097/01.AOG.0000270121.15510.57
32. Pang H Xu T Li Z Remission and transition of female urinary incontinence and its subtypes and the impact of body mass index on this progression: a nationwide population-based 4-year longitudinal study in China J Urol 2022 208 2 360 368 10.1097/JU.0000000000002686 35422135
Pang H, Xu T, Li Z, et al. Remission and transition of female urinary incontinence and its subtypes and the impact of body mass index on this progression: a nationwide population-based 4-year longitudinal study in China. J Urol. 2022;208(2):360–8.35422135 10.1097/JU.0000000000002686
33. de Oliveira MC Varella LR Angelo PH The relationship between the presence of lower urinary tract symptoms and waist circumference Diabetes Metab Syndr Obes 2016 9 207 211 10.2147/DMSO.S106221 27468244
de Oliveira MC, Varella LR, Angelo PH, et al. The relationship between the presence of lower urinary tract symptoms and waist circumference. Diabetes Metab Syndr Obes. 2016;9:207–11.27468244 10.2147/DMSO.S106221
34. Subak LL Wing R West DS Weight loss to treat urinary incontinence in overweight and obese women N Engl J Med 2009 360 5 481 490 10.1056/NEJMoa0806375 19179316
Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481–90.19179316 10.1056/NEJMoa0806375
35. Pang H Yin Y Xue J Associations between visceral adipose index and stress urinary incontinence among US adult women: a cross-sectional study World J Urol 2023 41 12 3671 3678 10.1007/s00345-023-04667-7 37921934
Pang H, Yin Y, Xue J, et al. Associations between visceral adipose index and stress urinary incontinence among US adult women: a cross-sectional study. World J Urol. 2023;41(12):3671–8.37921934 10.1007/s00345-023-04667-7
36. Cox AJ West NP Cripps AW Obesity, inflammation, and the gut microbiota Lancet Diabetes Endocrinol 2015 3 3 207 215 10.1016/S2213-8587(14)70134-2 25066177
Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–15.25066177 10.1016/S2213-8587(14)70134-2
37. Marcelissen T Anding R Averbeck M Exploring the relation between obesity and urinary incontinence: Pathophysiology, clinical implications, and the effect of weight reduction, ICI-RS 2018 Neurourol Urodyn 2019 38 Suppl 5 S18 S24 31821633
Marcelissen T, Anding R, Averbeck M, et al. Exploring the relation between obesity and urinary incontinence: Pathophysiology, clinical implications, and the effect of weight reduction, ICI-RS 2018. Neurourol Urodyn. 2019;38(Suppl 5):S18–24.31821633
38. Wyndaele M, Charrua A, Herve F et al. Beyond the urothelium: Interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury-ICI-RS 2023. Neurourol Urodyn. 2023;43(6):1283–92.
39. Lizcano F Guzman G Estrogen deficiency and the origin of obesity during menopause Biomed Res Int 2014 2014 757461 10.1155/2014/757461 24734243
Lizcano F, Guzman G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int. 2014;2014:757461.24734243 10.1155/2014/757461
40. de Vries AM Venema PL Heesakkers J Midurethral support is also necessary for reflex closure of the urethra Neurourol Urodyn 2018 37 8 2965 2972 10.1002/nau.23807 30187966
de Vries AM, Venema PL, Heesakkers J. Midurethral support is also necessary for reflex closure of the urethra. Neurourol Urodyn. 2018;37(8):2965–72.30187966 10.1002/nau.23807
41. Tang F Zhang J Huang R The association between wet overactive bladder and consumption of tea, coffee, and caffeine: Results from 2005–2018 National Health and Nutrition Examination Survey Clin Nutr 2024 43 6 1261 1269 10.1016/j.clnu.2024.03.027 38653009
Tang F, Zhang J, Huang R, et al. The association between wet overactive bladder and consumption of tea, coffee, and caffeine: Results from 2005–2018 National Health and Nutrition Examination Survey. Clin Nutr. 2024;43(6):1261–9.38653009 10.1016/j.clnu.2024.03.027
42. Hagovska M Svihra J Bukova A The impact of different intensities of exercise on body weight reduction and overactive bladder symptoms- randomised trial Eur J Obstet Gynecol Reprod Biol 2019 242 144 149 10.1016/j.ejogrb.2019.09.027 31590034
Hagovska M, Svihra J, Bukova A, et al. The impact of different intensities of exercise on body weight reduction and overactive bladder symptoms- randomised trial. Eur J Obstet Gynecol Reprod Biol. 2019;242:144–9.31590034 10.1016/j.ejogrb.2019.09.027
